14 results
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
- An Official ATS ... expansion and relief ... care (intravenous antibiotics ... Effusions #MPE #Algorithm ... #Management #ATS
Linezolid (Zyvox) (PO and IV) - Antibiotics Class Overview

Mechanism: Oxazolidinone class –unique ribosomal inhibitor (acts on
(PO and IV) - Antibiotics ... ribosomal inhibitor (acts ... infections #Pharmacology ... #Antibiotics #Review
How should the modified Sgarbossa Criteria be used in initial evaluation of patients with suspected AMI
How should the modified ... AMI with LBBB should ... - Hemodynamic instability ... AcuteCoronarySyndrome #ACS ... LBBB #Evaluation #Algorithm
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Flutycosine - Antibiotics ... Virtually never used as ... - Drug levels should ... #Pharmacology #Antibiotics ... #Review #Overview
Oral Antibiotics for Acne - Indicated for Moderate-to-Severe Acne 
First-Line Drug Class: Tetracyclines 

In the last
Oral Antibiotics ... the last post I reviewed ... talk about oral antibiotics ... However, they should ... #Pharmacology #
Blood Culture Collection Algorithm - Adult Patients with Suspected Systemic Infection 

Pawlowicz et al evidenced based
General Guidelines ... level of care such as ... blood cultures should ... blood cultures should ... obtained prior to antibiotic
ANTIBIOTICS WITH ANAEROBE COVERAGE - Antibiotics Class Overview
 1. Metronidazole (Flagyl)(PO and IV)
 2. Clindamycin –
ANTIBIOTICS WITH ... ANAEROBE COVERAGE - Antibiotics ... the diaphragm, as ... #Pharmacology #Antibiotics ... #Review #Overview
COPD Management Algorithm - GOLD 2019 guidelines 

Categorize into COPD GOLD A-D -> Initiate first-line therapy
COPD Management Algorithm ... what to initiate as ... ICS use should only ... Management #Pulmonary #Algorithm ... #pharmacology
Esophageal Variceal Bleeding - Scoping Summary
GENERAL PRINCIPLES OF MANAGEMENT (VARICEAL-B):
V - Vasoconstrictor therapy: (Octreotide 50mcg bolus
2-5 days) A - Antibiotics ... do not extent as ... active hematemesis, AMS ... to AGA practice guidelines ... diagnosis #management #algorithm
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
- An Official ATS ... Practice Guideline ... expansion and relief ... care (intravenous antibiotics ... #Algorithm #Effusion